patient-access
(9)
Chetan Reddy
Chetan Reddy is the co-founder and CEO of Confido Health, a New York based startup building AI voice and messaging agents that answer patient calls around the clock and complete routine front-office work like scheduling, refills, eligibility checks and reminders. He started the company after watching the administrative load of the US healthcare system firsthand when his wife had spine surgery, and has grown Confido to more than 1,000 clinical sites and millions of patient interactions. An engineer by training from BITS Pilani, he previously built AI systems for drone mapping and a fitness app before turning to healthcare operations.
Greg Peters
Greg Peters is the co-founder and CEO of BetterHealthcare, a New York-based healthcare technology company that started as BetterPT in 2016 and grew into an interoperable patient-access and scheduling platform. A former Division I football player and New York fitness professional, he partnered with Hospital for Special Surgery surgeon Dr. Stephen Fealy to remove the friction in booking physical therapy and, later, broader care. BetterHealthcare was acquired by HealthBus in January 2025, where its BetterAccess platform now powers real-time appointment booking and provider matching across a national network.
Dan Rubin
Dan Rubin is President and CEO of PARx Solutions, a Burlington, Massachusetts healthtech company that runs the Prior Authorization Support System (PASS), a service that helps physician offices push prescriptions past insurer prior-authorization roadblocks at no cost to the practice. A chemical engineer by training who switched to building businesses, Rubin co-founded medication-adherence pioneer Adheris in 1993, ran it for fifteen years, then took the helm at PARx in 2012. He has spent three decades on a single problem: the gap between a doctor writing a prescription and a patient actually getting the medicine.
Eesha Sharma
Eesha Sharma is the founder and CEO of Lamar Health, a Y Combinator-backed (W21) startup that uses AI to automate the mountain of paperwork standing between patients and high-cost specialty drugs. A genetics PhD from the University of Toronto and former Stanford postdoc, she traded antisense-oligonucleotide research for the unglamorous fight against prior-authorization bureaucracy after watching a family member endure years of misdiagnosis. Lamar Health now serves specialty pharmacies, infusion clinics and hospitals, automating prior auths, document review and EHR connectivity for medications that average roughly $70,000 a year per patient.
Jon Wang
Jon Wang is the co-founder and co-CEO of Assort Health, a San Francisco company building voice AI agents that answer the phone for doctors' offices. A Stanford bioinformatics graduate and Gates-Cambridge Scholar who walked away from UCSF medical school, Wang spent two years studying why patients wait on hold before launching Assort with Jeff Liu in 2023. The company has since handled more than 42 million patient interactions and raised $102 million, including a $76 million Series B led by Lightspeed in 2025.
Richard Fine
Richard Fine is Chief Business Officer at Zocdoc, where for more than a decade he has helped turn a doctor-booking marketplace into what he calls 'healthcare access infrastructure.' A two-time founder with two exits, he built Help Remedies, the over-the-counter brand that made aspirin boxes funny and won a Cannes Lion, and spent years as a brand strategist at Redscout working with Nike, PepsiCo and Diageo. Oxford-trained in Philosophy, Politics and Economics and raised by two epidemiology professors, he frames his work simply: he loves healthcare and hates its incentives, and at Zocdoc he gets to fix both.
Syam Palakurthy
Syam Palakurthy is the co-founder and CEO of SamaCare, a San Francisco healthcare-technology company that rips paper and fax out of the specialty-drug prior authorization process. After a Dartmouth engineering-and-economics degree and a stint at Bain (where he once asked to be staffed on anything but healthcare), he built a cloud platform that now connects 15,000+ providers across retina, oncology, neurology, and rheumatology, and has raised roughly $35 million to make getting a patient on therapy 'as simple as a credit card swipe.'
Josh Rose
Josh Rose is the CEO of Hawthorne Health, Inc. (formerly Hawthorne Effect), a Walnut Creek-based company building the largest community-based clinical trial site network in the U.S. A clinical research industry veteran with over 20 years of experience, Rose previously led decentralized clinical trial strategy at IQVIA and CVS Health before taking the helm at Hawthorne Health in early 2024. Under his leadership, Hawthorne has expanded to 75+ community locations, partnered with 40+ pharma sponsors, and pioneered a model that embeds certified clinical research staff inside independent pharmacies and patients' homes - bringing trials to communities that traditional research networks have long bypassed.
Pranay Kapadia
Pranay Kapadia is the Co-Founder and CEO of Notable, an AI-powered automation platform for healthcare that eliminates administrative burden for clinicians and health systems. Founded in 2017 after dinner-table conversations with six physician family members - including his psychiatrist wife who called herself 'the highest paid data collector in the world' - Notable has grown to serve 32 million patients across 12,000 sites of care, raised $119.2M in funding including a $100M Series B in 2021, and now automates over one million repetitive healthcare workflows daily. Before Notable, Kapadia helped build Mint.com at Intuit and was on the founding team at Blend, the mortgage fintech unicorn.